Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy
Authors
Keywords
-
Journal
EUROPEAN RADIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-11
DOI
10.1007/s00330-022-08648-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
- (2021) S. Rao et al. ANNALS OF ONCOLOGY
- UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes
- (2020) A. Gilbert et al. EUROPEAN JOURNAL OF CANCER
- Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors
- (2019) Espen Rusten et al. BRITISH JOURNAL OF RADIOLOGY
- FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial
- (2019) Michael Peter Jones et al. Radiation Oncology
- Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial 18F-FDG PET/CT
- (2019) Jiahui Wang et al. Frontiers in Oncology
- Accuracy of FDG PET-CT response assessment following radiotherapy alone for head and neck squamous cell carcinoma: Retrospective analysis of 45 patients
- (2018) J. Philip et al. CLINICAL OTOLARYNGOLOGY
- FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance
- (2018) Nils Helsen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of 18 F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma
- (2017) Clémence Houard et al. JOURNAL OF NUCLEAR MEDICINE
- Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI
- (2017) Carole Durot et al. KOREAN JOURNAL OF RADIOLOGY
- Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy
- (2016) Andrew Scarsbrook et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer
- (2016) Rohit Kochhar et al. EUROPEAN RADIOLOGY
- International trends in anal cancer incidence rates
- (2016) Farhad Islami et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer
- (2016) Alexandra R. Teagle et al. NUCLEAR MEDICINE COMMUNICATIONS
- Advances in the Management of Anal Cancer
- (2016) Diana R. Julie et al. Current Oncology Reports
- The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis
- (2015) Michael Jones et al. ANNALS OF SURGICAL ONCOLOGY
- Assessment of outcomes with delayed18F-FDG PET-CT response assessment in head and neck squamous cell carcinoma
- (2015) F Slevin et al. BRITISH JOURNAL OF RADIOLOGY
- Safety and cost analysis of an 18FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation
- (2015) Ketan Shah et al. ORAL ONCOLOGY
- Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Glynne-Jones et al. ANNALS OF ONCOLOGY
- The Role of MRI in the Assessment of the Local Status of Anal Carcinomas and in Their Management
- (2014) É. Jederán et al. PATHOLOGY & ONCOLOGY RESEARCH
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial
- (2013) Roger D James et al. LANCET ONCOLOGY
- Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up
- (2012) Sachin S. Saboo et al. ABDOMINAL IMAGING
- Role of Positron Emission Tomography-Computed Tomography in the Management of Anal Cancer
- (2012) Massimiliano Mistrangelo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The epidemiology of anal cancer
- (2012) Andrew E. Grulich et al. Sexual Health
- 18F-FDG PET/CT of Cervical Carcinoma
- (2011) Chirag N. Patel et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
- (2011) F L Day et al. BRITISH JOURNAL OF CANCER
- Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer
- (2011) Shankar Siva et al. CANCER
- Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma
- (2010) Laetitia Vercellino et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Magnetic Resonance Imaging Assessment of Squamous Cell Carcinoma of the Anal Canal Before and After Chemoradiation: Can MRI Predict for Eventual Clinical Outcome?
- (2010) Vicky Goh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation
- (2008) D M KOH et al. BRITISH JOURNAL OF RADIOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Assessing the impact of FDG-PET in the management of anal cancer
- (2008) Brandon T. Nguyen et al. RADIOTHERAPY AND ONCOLOGY
- Tumor Response and Survival Predicted by Post-Therapy FDG-PET/CT in Anal Cancer
- (2007) Julie K. Schwarz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More